Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: INJECTABLE; INTRAMUSCULAR
Strength: 10MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217466
Product Number: 001
Approval Date: Mar 22, 2023
Applicant Holder Full Name: ASPIRO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
